05:32 PM EST, 02/27/2025 (MT Newswires) -- TransMedics Group ( TMDX ) reported Q4 net income late Thursday of $0.19 per diluted share, up from $0.12 a year earlier.

Analysts polled by FactSet expected $0.13.

Revenue in the three months ended Dec. 31 rose to $121.6 million from $81.2 million a year earlier.

Analysts surveyed by FactSet expected $109.6 million.

The company expects 2025 revenue of $530 million to $552 million. Analysts polled by FactSet expect $522.4 million.

Shares of TransMedics ( TMDX ) rose 4.4% in after-hours trading.